(Q36563145)

14 August 2017

HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro (English)

1 reference

14 August 2017

Xiao-Lin Lin

1

1 reference

14 August 2017

Xiao-Li Wang

2

1 reference

14 August 2017

Bo Ma

3

1 reference

14 August 2017

Jun Jia

4

1 reference

14 August 2017

Ying Yan

5

1 reference

14 August 2017

Li-Jun Di

6

1 reference

14 August 2017

Yan-Hua Yuan

7

1 reference

14 August 2017

Feng-Ling Wan

8

1 reference

14 August 2017

Yuan-Li Lu

9

1 reference

14 August 2017

Xu Liang

10

1 reference

14 August 2017

Tao Shen

11

1 reference

14 August 2017

Jun Ren

12

1 reference

14 August 2017

1 June 2012

1 reference

Chinese Journal of Cancer Research

14 August 2017

1 reference

14 August 2017

24

1 reference

14 August 2017

2

1 reference

14 August 2017

143-150

1 reference

14 August 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Mechanisms of resistance to anti‐human epidermal growth factor receptor 2 agents in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Anti-HER2 vaccines: new prospects for breast cancer therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Evolving novel anti-HER2 strategies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Stemming resistance to HER-2 targeted therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Gene therapy using adeno-associated virus vectors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Cancer immunotherapy by dendritic cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Genetically modified dendritic cells for cancer immunotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

ERBB receptors and cancer: the complexity of targeted inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (review).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Molecular portraits of human breast tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Antigen-binding function of class II MHC molecules

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Decreased antigen presentation by dendritic cells in patients with breast cancer.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3555268

Breast cancer: Increasing therapy options for HER2-positive early breast cancer

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23357961

12 December 2020

inferred from PubMed ID database lookup

Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23357961

12 December 2020

inferred from PubMed ID database lookup

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23357961

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11670-012-0143-6

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wpkltg5zkffd5owxtz2bqvxlpm

30 July 2022

release_wpkltg5zkffd5owxtz2bqvxlpm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wpkltg5zkffd5owxtz2bqvxlpm

30 July 2022

https://api.fatcat.wiki/v0/release/wpkltg5zkffd5owxtz2bqvxlpm

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/wpkltg5zkffd5owxtz2bqvxlpm

PubMed publication ID

1 reference

30 July 2022